Pharmacist Issued Public Warning for Supplying Oramorph Without Prescription
Date of Decision: April 28, 2025
Registrant's Role: Pharmacist
Allegations:
- Supplied Oramorph, a Schedule 5 Controlled Drug and prescription-only medicine (POM), to another healthcare professional without a valid prescription.
- Failed to meet the legal criteria for an emergency supply and did not create a proper audit trail.
- Did not attach a dispensing label or retain a legally required record.
Outcome: Formal warning issued
GPhC Standards Breached:
- Standard 5 – Use professional judgement
- Standard 6 – Behave in a professional manner
- Standard 9 – Demonstrate leadership
Case Summary
The General Medical Council raised a concern regarding the registrant’s conduct. The registrant had:
- Supplied Oramorph (morphine sulfate) to a doctor (“Dr A”) for potential use in the doctor’s son’s post-operative pain.
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.